SCHEMBL2575822

SCHEMBL2575822

C[AsH]C1CCN(c2cc(C34CC5CC(CC(C5)C3)C4)nc(N)n2)C1

nearest known ligand 0.70

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 17/20 0.70
HRH3 Q9Y5N1 2/20 0.40
HTR6 P50406 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2575818 1.00 HRH4 (0.70) HRH4HRH3HTR6
SCHEMBL604181 0.82 HRH4 (1.00) HRH4HRH3
SCHEMBL604180 0.82 HRH4 (1.00) HRH4HRH3
SCHEMBL602671 0.79 HRH4 (0.63) HRH4HRH3HTR6
SCHEMBL17088142 0.66 HRH4 (0.47) HRH4HTR6
SCHEMBL7774534 0.63 HRH4 (0.55) HRH4HRH3
SCHEMBL605884 0.62 HRH4 (0.55) HRH4HRH3
SCHEMBL605885 0.62 HRH4 (0.55) HRH4HRH3
SCHEMBL4367035 0.62 HRH4 (0.63) HRH4HRH3
SCHEMBL4367029 0.62 HRH4 (0.63) HRH4HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9688989-B2 H4 receptor inhibitors for treating tinnitus SENSORION (FR) 2017-06-27 US disclosed
EP-3130376-A1 SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF VESTIBULAR DISORDERS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2017-02-15 EP disclosed
EP-2382013-B1 SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF VESTIBULAR DISORDERS. INSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE (FR) 2016-07-13 EP disclosed
US-20150176010-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS SENSORION (FR) 2015-06-25 US disclosed
EP-2382013-A1 SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF VESTIBULAR DISORDERS. INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2011-11-02 EP disclosed
WO-2010072829-A1 SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF VESTIBULAR DISORDERS. INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2010-07-01 WO disclosed